











































In-Hospital Mortality Risk Model of Gastric Cancer Surgery
Citation for published version:
Wu, Z, Cheng, H, Shan, F, Ying, X, Miao, R, Dong, J, Sun, Y, Xu, A, Zhou, Y, Wang, Y, Chen, L, Xue, Y,
Cao, H, Hua, Y, Xu, Z, Zheng, M, Yan, M, Huang, C, Suo, J, Liang, H, Fan, L, Hu, J, Hu, X, Li, G, Yu, P, Li,
G, Shi, Y, Luo, H, Li, Y, Xie, M, Liu, T, Zhang, Z, Shi, T, Li, Z & Ji, J 2019, 'In-Hospital Mortality Risk Model
of Gastric Cancer Surgery: Analysis of a Nationwide Institutional-Level Database With 94,277 Chinese
Patients', Frontiers in Oncology, vol. 9, pp. 846. https://doi.org/10.3389/fonc.2019.00846
Digital Object Identifier (DOI):
10.3389/fonc.2019.00846
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:




This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the
copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with
accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these
terms.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 23. Jul. 2021
ORIGINAL RESEARCH
published: 01 October 2019
doi: 10.3389/fonc.2019.00846

















†These authors have contributed
equally to this work
Specialty section:
This article was submitted to
Surgical Oncology,
a section of the journal
Frontiers in Oncology
Received: 28 May 2019
Accepted: 19 August 2019
Published: 01 October 2019
Citation:
Wu Z, Cheng H, Shan F, Ying X,
Miao R, Dong J, Sun Y, Xu A, Zhou Y,
Wang Y, Chen L, Xue Y, Cao H, Hua Y,
Xu Z, Zheng M, Yan M, Huang C,
Suo J, Liang H, Fan L, Hu J, Hu X,
Li G, Yu P, Li G, Shi Y, Luo H, Li Y,
Xie M, Liu T, Zhang Z, Shi T, Li Z and
Ji J (2019) In-Hospital Mortality Risk
Model of Gastric Cancer Surgery:





In-Hospital Mortality Risk Model of
Gastric Cancer Surgery: Analysis of a
Nationwide Institutional-Level
Database With 94,277 Chinese
Patients
Zhouqiao Wu 1†, Huimin Cheng 2†, Fei Shan 1, Xiangji Ying 1, Rulin Miao 1, Jianhong Dong 3,
Yihong Sun 4, Aman Xu 5, Yanbing Zhou 6, Yanong Wang 7, Lin Chen 8, Yingwei Xue 9,
Hui Cao 10, Yawei Hua 11, Zekuan Xu 12, Minhua Zheng 10, Min Yan 10, Changming Huang 13,
Jian Suo 14, Han Liang 15, Lin Fan 16, Jiankun Hu 17, Xiang Hu 18, Guoli Li 19, Peiwu Yu 20,
Guoxin Li 21, Yiran Shi 22, Huayou Luo 23, Yong Li 24, Ming Xie 25, Tianxue Liu 26,
Zhongyuan Zhang 2, Ting Shi 27, Ziyu Li 1* and Jiafu Ji 1*
on behalf of China Gastrointestinal Cancer Surgery Union
1 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal
Surgery, Peking University Cancer Hospital and Institute, Beijing, China, 2 School of Statistics and Mathematics, Central
University of Finance and Economics, Beijing, China, 3Center of Minimally Invasive Gastrointestinal Surgery, Shanxi Provincial
Cancer Hospital, Taiyuan, China, 4Department of General Surgery, Fudan University Zhongshan Hospital, Shanghai, China,
5Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China, 6Department of
General Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China, 7Department of Gastric Cancer and Soft
Tissue Sarcomas, Fudan University Shanghai Cancer Hospital, Shanghai, China, 8Department of General Surgery, People’s
Liberation Army General Hospital, People’s Liberation Army (PLA) Army General Hospital, Beijing, China, 9Department of
Gastrointestinal Surgery, Harbin Medical University Cancer Hospital, Harbin, China, 10Department of General Surgery, Ruijin
Hospital, Shanghai Jiao Tong University, Shanghai, China, 11Department of General Surgery, Henan Cancer Hospital,
Zhengzhou, China, 12Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing,
China, 13Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China, 14Department of
Gastrointestinal Surgery, The First Hospital of Jilin University, Changchun, China, 15Department of Gastric Cancer, Tianjin
Medical University Cancer Institute and Hospital, Tianjin, China, 16Department of General Surgery, The First Affiliated Hospital
of Xi’an Jiaotong Hospital, Xi’an, China, 17Department of Gastrointestinal Surgery, West China Hospital, Chengdu, China,
18Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, China, 19Department of
Gastrointestinal Surgery, Nanjing General Hospital, Nanjing, China, 20Department of General Surgery, The First Hospital
Affiliated Hospital to Army Medical University (AMU) (Southwest Hospital), Chongqing, China, 21Department of General
Surgery, Nanfang Hospital, Guangzhou, China, 22Department of General Surgery, Weifang People’s Hospital, Weifang, China,
23Department of Gastrointestinal Surgery, First Affiliated Hospital of Kunming Medical University, Kunming, China,
24Department of General Surgery, Guangdong General Hospital, Guangzhou, China, 25Department of General Surgery,
Affiliated Hospital of Zunyi Medical University, Zunyi, China, 26Department of General Surgery, Penglai People’s Hospital,
Penglai, China, 27Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics,
University of Edinburgh, Edinburgh, United Kingdom
Background: The objective of this study is to identify independent risks and
protective factors and to construct a mortality prediction model for gastrectomy in the
Chinese population.
Study design: This is a population-based prospective cohort at an institutional level.
Seventy-two participating hospitals reported their annual gastrectomy data between
2014 and 2016, while 44 variables covering the institution and surgical information
were included in the analysis. We used R software to encode and complete data
pre-processing. The first difference model was applied to build the risk model. Data from
2014 and 2015 were assigned to risk model development, while data from 2016 was
used for validation.
Wu et al. Analysis of Chinese Gastrectomy Database
Results: In the included centers with 94,277 gastric cancer cases, the in-hospital
mortality rate was 0.32%. The regression model revealed that provinces with low-middle
GDP, hospitals with annual gastrectomy volume between 100 and 500, greater volume
of urgent surgeries performed, larger proportion of males, and a higher proportion of
liver metastasis were independent risk factors for mortality following gastric surgeries,
while higher laparoscopic resection volume, greater volume of distal gastrectomy with
B2 reconstruction, and larger proportion of palliative surgery were independent protective
factors (p< 0.05, respectively). In the prediction test, themean square error of the training
set was 0.948, while that of the test set was 0.728, demonstrating the effectiveness of
this model.
Conclusions: We constructed the first mortality risk prediction model for gastric cancer
surgery in the Chinese population. The identified risk factors will help with the therapy
selection, while further informing Chinese medical policy decision-makers.
Keywords: gastric cancer, surgical safety, mortality, national database, prediction model
INTRODUCTION
Gastric cancer is still a common global malignancy with over
one million new cases each year, where more than half occurs
in China. It remains the second most commonly diagnosed
cancer in the ethnic Chinese population (1). Although early stage
cases can be treated with endoscopic therapy, the majority of
cases are already locally advanced at the time of diagnosis, in
which case, surgical resection is obligatory for the treatment.
Despite the steady improvement of oncological survival in the
recent decades, surgical complications after gastrectomy are still
fairly common (18.3–36%) (2–4). Major complications including
anastomotic leakage, peritonitis, bleeding, and ileus could
significantly hinder postoperative recovery, or even threaten the
patient’s life if not properly managed (5). Mere delays in recovery
also postpone adjuvant therapy, which may influence oncological
survival, let alone intra-abdominal infectious complications,
which are associated with earlier recurrence and reduced long-
term survival rates (6, 7).
To reduce postoperative mortality and complications, the
medical infrastructure has seen a rise in the number of national
surgical databases, producing invaluable findings to inform both
domestic and international medical communities (8–10). The
China Gastrointestinal Cancer Surgical Union was founded in
2016 for the purpose of improving surgical quality and safety in
China by documenting and sharing cases. As the first step, we
collected the annual summary of 72 participating medical centers
with nearly 200,000 gastric and colorectal patient data in China
between 2014 and 2016, and created the China Gastrointestinal
Surgery Database (CGSD). Using this database, we constructed




The CGSD was established for risk factor stratification of
gastric and colorectal cancer surgery in the Chinese population.
All member institutions must submit its annual institutional
summary data to the central database. The CGSD’s final structure
is expected to be similar to the ACS-NSQIP (American College
of Surgeons—National Surgical Quality Improvement Program)
and the Japanese NCD (National Clinical Database) programs
(2, 9), which yield a collection of individual-level data in
the form of patients’ demographic characteristics, pre-existing
comorbidities, pre-operative laboratory results, surgical details,
and postoperative outcomes. The majority of the participating
centers are tertiary hospitals, covering 88.2% (30/34) provinces of
China, with 94,277 gastric and 90,076 colorectal cancer patients’
data collected between 2014 and 2016.
One of the ultimate goals of the CGSD is to predict
institutional mortality, we therefore developed a prediction
model in this study. We assigned data from 2014 and 2015 to the
risk model development (training set), while data from 2016 was
used for prediction model validation (test set).
Data Collection
Each participating institution reported their annual summary
data of gastric cancer surgeries. In total, 44 variables were
included in the analysis, including institution information
(e.g., hospital name, hospital type, annual gastrectomy volume,
number of surgeons, and beds in the team etc.), and surgical
information (e.g., number of open and laparoscopic gastrectomy,
number of total, distal and proximal gastrectomy, number
of different reconstruction types, number of surgery after
neoadjuvant therapy, number of palliative surgery etc.).
Endpoints of the Study
In this study, we used in-hospital mortality as our primary
endpoint. It was defined as death during the hospitalization of
the surgical treatment, regardless of the length of hospital stay or
cause of death. In addition, the other safety parameters including
re-operation rate and post-operative stay were selected as the
secondary endpoints.
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Data Analysis
We used R (Version 3.3.2) software to encode and complete data
pre-processing automatically. For the missing data, we imputed
them by applying K-nearest neighbor (KNN). The proportion
of missing data were <10% of all included variables, and most
variables (40/44) had <5% of missing data (Table S1). The 3-
year average of variables of interest were described as mean
(min. to max). If not indicated, the averages were weighted by
center volume.
In the training set, we used the first difference model for
the prediction model, because it could circumvent the issue of
non-independence of repeated measurements in each center.
This model has been frequently used for the purposes of trend






where 1y and 1xi denote the first difference in response and
predictors respectively. In other words, 1yt = yt − yt−1, 1xit =
xit − xit−1, where t represents time, that is, different years of this
study. βi represents the influence of a unit of change in 1xit on
1yt (12, 13), and et denotes the residual. For example, βi = 3
means that if xi increases by 1 unit at time t, then y will increase
by 3 units at time t.
In the section of prediction validation (test set), mean square
error (MSE) is applied to evaluate the accuracy of the model









where Yi and Ŷi denotes the observed and predicted value (Yi −
Ŷi), is known as residual. Lower MSE means better prediction
accuracy. An MSE of zero, meaning that the estimators Ŷi
predicts observations Yi with perfect accuracy.
All data analyses were conducted using R (version 3.3.2). A
two-sided P value <0.05 is considered as statistical significance.
No ethical approval nor informed consent was required for this
study under the domestic legislation.
RESULTS
Demographic Characteristics
There are 72 hospitals reported the gastric cancer data to the
database. Among them, 78% are general hospitals while the other
22% are cancer hospitals.
The average annual volume of gastric cancer surgery per
institution was 585, which was conducted by an average of 9.6
surgeons per hospital. The average volume of open gastrectomy
was 260.1 cases per year, while that of the laparoscopic ones was
135.2 cases per year. The average number of harvested lymph
nodes was 27.4. A summary of the demographic characteristics
is listed in Table 1.
Mortality
The in-hospital mortality rate was 0.3% (0–3.6%), and the other
surgical safety outcomes are summarized in Table 2.
Predictive Factors
The regression model revealed that low/middle GDP provinces,
annual gastrectomy volume between 100 and 500, greater
numbers of urgent surgeries performed due to bleeding or
obstruction, higher reoperation rate, greater proportion of male
patients, and a greater proportion of liver metastasis were
independent risk factors for mortality after gastric surgery, while
higher laparoscopic resection volume, higher distal gastrectomy
with B2 reconstruction volume, and higher proportion of
palliative surgery were the independent protective factors
(p < 0.05 respectively, Table 3). All risks and protective factors
listed above were measured at an institutional level.
Prediction Model Evaluation
The gastric mortality-risk prediction model shows that the MSE
of the training set was 0.948, while that of the test set was 0.728.
Most residuals in the model are concentrated near 0. The low
MSE in themodel shows the effectiveness of our predictive model
(Figure 1).
DISCUSSION
This is the first report, based on the large-scale national surgical
database that we have recently established, of institution-level
risk stratification and in-hospital mortality prediction on gastric
cancer surgeries in China.
The in-hospital mortality rate of gastric cancer surgery
was 0.32% in our database, varying between 0 and 3.6% in
different participating centers. This is comparable to the results
from other Asian countries (0.3–1.2%) (3, 14), and seems
lower than some studies from Europe or America (4.7–10%)
(2, 8, 15). However, such difference cannot simply be explained
by surgical quality or safety. One obvious reason is that the
disease epidemiology (including severity) varied across regions,
which substantially varied the surgical difficulties in different
areas. Another possible explanation is that many other national
databases also include emergency surgery with non-malignant
causes, which may substantially increase the mortality [0.7 vs.
6.0% for right hemicolectomy (16)], while our database primarily
focuses on cases of cancer. Although some urgent cases due to
bleeding or obstruction were still performed (and those were
indeed identified as risk factors in the results), the majority of the
cases were elective procedures.
We chose in-hospital mortality rather than the 30-day
mortality (a more frequently used parameter for surgical safety
evaluation) as the primary endpoint in CGSD. This is because
of the currently unsatisfactory follow-up system. In China, most
gastric cancer patients are treated in tertiary hospitals in the
cities (17), however many of the patients continue their follow-
up treatment in the primary hospitals that are distant from
the cities. In this case, it is difficult to obtain follow-up data
updates, therefore, in-hospital mortality is a more practical
and reliable parameter to evaluate the surgical safety in the
current circumstances.
Many of our identified risk factors were also reported
in the previous literature, such as urgent surgery (bleeding,
obstruction) (4), and greater male proportion (3). In addition,
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TABLE 1 | Summary of demographic characteristics.
Parameter Mean Mean’ Min Max Preprocessing
Provincial GDP level – – – – Divided into 4 categories in decreasing order by the
GDP of the hospital: 34.72, 33.33, 16.67, 15.28%
Hospital Type – – – – Divided into: General hospital (78%), Cancer
hospital (22%)
Male proportion 68.88% 68.97% 46.09% 81.41% Number of Male patients/Number of all patients
Average Age 59.86 59.71 52.57 67.06
Number of beds for gastric cancer surgery 78.76 80.77 15 328
Number of gastric cancer surgeons 9.64 9.79 2 40
Average surgeon per bed 0.14 0.14 0.03 0.67 Number of surgeons/number of beds
Annual gastrectomy volume level – – – – Divided into 3 levels: <100(9.09%),
100–500(44.16%), >500 (46.75%)
Urgent surgery volume due to bleeding
or obstruction
25.49 25.41 2 53
Open gastrectomy volume 260.12 267.30 0* 1277
Open total gastrectomy volume 113.02 115.7 0* 771
Open distal gastrectomy volume 134.73 138.76 0* 495
Open proximal gastrectomy volume 29.12 29.02 0* 345
Laparoscopic resection volume 135.17 118.95 0* 614
Laparoscopic total gastrectomy volume 52.66 46.30 0* 464
Laparoscopic distal gastrectomy volume 77.44 68.45 0* 378
Laparoscopic proximal gastrectomy volume 7.40 5.80 0* 84
Number of average harvested lymph nodes 27.40 27.18 8 62
Liver metastasis proportion 2.01% 2.06% 0% 21.69% Number of liver metastasis/gastrectomy volume
Palliative surgery proportion 2.06% 1.87% 0% 12.39% Palliative surgery volume/gastrectomy volume
Mean’ indicates the weighted average value of the training dataset (2014–2015).
*Due to the fact that a few hospitals only conduct open gastrectomy or laparoscopic gastrectomy (with a few conversions), the number of 0 was reported, respectively.
TABLE 2 | Surgical safety and recovery outcomes.
Outcomes (min. to max.) Mean Mean’
Mortality, % 0.32(0–3.6) 0.35
Reoperation rate, % 1.46(0–7.08) 1.55
Postoperative stay, days 15.69 (7.50–26) 16.10
Mean’ indicates the weighted average value of the training dataset (2014–2015).
our data supports the application of laparoscopy in gastric cancer
patients, as the laparoscopic resection volume was identified as
a protective factor. The advantages of the laparoscopic approach
in colorectal surgery has now reached consensus among doctors,
while its application in gastric cancer surgery remains in the
early stage cases. The protective effect of the higher laparoscopic
volume may be partly explained with the higher number of
early stage cases in those centers, since the surgical procedures
are standardized and face fewer technical difficulties. Similarly,
the safety analysis of the CLASS-01 (Chinese Laparoscopic
Gastrointestinal Surgery Study-01) trial has supported the use of
laparoscopy in locally advanced gastric cancer cases (18), with
similar oncological survival outcomes compared to the open
procedures (19).
Higher liver metastasis proportion and higher palliative
surgery proportion were identified as risk and protective factors,
respectively, in our study. This is in agreement with the
NCCN (National Comprehensive Cancer Network) and Japanese
guidelines, which are, in general, against surgical therapy in M1
patients (20, 21). The surgical complexity and surgical trauma
to multiple organs may explain the higher mortality in this
type of patients. Yet, the Japanese guidelines also emphasize
the possibility of hepatectomy for patients with a small number
of metastatic nodules (20). A recent systematic review suggests
better survival rates in favor of hepatectomy in this group
of patients (22). With the recent advances in chemotherapy,
more hepatectomies are performed for those gastric cancer
patients with resectable nodules after conversion therapy. Our
data address the short-term risks of this complex procedure,
emphasizing the importance of safety evaluation when designing
the surgical plan.
In addition to the aforementioned disease associated factors,
our analysis also revealed many institutional factors which
might influence mortality rates. Low GDP province and low
annual volume seem to increase the in-hospital mortality of
gastric cancer surgery. Similar results were also reported in
the other literature (23, 24). One of the solutions for this is
to relocate patients to select surgical theaters for complicated
surgeries. Many European countries with low incidence of
gastric cancer have applied this concept in practice by referring
those patients to certain centers for gastrectomy (25). Greater
volume often implies a greater level of technical competence
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TABLE 3 | Risk model of in-hospital mortality.
Variables Status Parameter estimation 95% CI P-value
Provincial GDP level middle-low GDP 0.97 0.37 to 1.57 0.002
Annual gastrectomy volume 100–500 0.75 0.10 to 1.40 0.002
Liver metastasis proportion higher proportion 0.42 0.25 to 0.59 <0.001
Male patient proportion higher proportion 0.23 0.08 to 0.37 0.004
Reoperation rate higher rate 0.18 0.01 to 0.35 0.0380
Urgent surgery volume Yes 0.17 0.02 to 0.33 0.027
Distal gastrectomy with B2
reconstruction volume
higher volume −0.32 −0.54 to (−0.10) 0.005
Palliative surgery proportion higher proportion −0.32 −0.53 to (−0.12) 0.003
Laparoscopic resection volume higher volume −0.36 −0.69 to (−0.03) 0.037
FIGURE 1 | Residual distribution of gastric cancer mortality prediction model.
Residual calculates the difference between the actual and predicted value.
from surgeons, which may result in enhanced safety outcomes
(8, 24, 26). In addition, higher volume centers often indicate
high-intensity intensive care units, the additional availability of
multi-disciplinary teams and interventional radiology, effective
prevention, and management of complications. These factors
also influence the postoperativemortality (26). However, whether
concentrating gastric cancer surgery fits the needs of the medical
environment in China requires more research and discussion,
given its large population and vast territories.
Distal gastrectomy was found to be a protective factor for
mortality. This is in accordance with the literature reporting
that distal gastrectomy is associated with fewer complications
and thus lower in-hospital mortality when compared to
the Japanese NCD data of distal and total gastrectomy
(3, 4). Unfortunately, post-operative safety outcomes, i.e.,
complications, were not documented in a standardized manner
in CGSD. It should be emphasized that morbidity remains
substantial after gastrectomy. Our database also required
complication rate data from each participant, but it varied
between 0.3 and 33.1%. This is mainly because of the lack
of standardized complication registration in China. Given that
our union was devoted to this subject and has published the
first consensus for standardized complication diagnosis and
registration in China (27), several on-going prospective cohort
studies are expected to reveal the complication rate and its
severity after gastric cancer surgery in China. We believe these
efforts would result in better data quality and thus better surgical
outcomes in the future.
Considering the overall number of centers performing
gastrectomy in China, our database has collected a portion of
them and the majority are tertiary (3A-level) hospitals, which
inevitably introduced selection bias in the current research.
However, given the fact that most gastric cancer cases are
treated in 3A-level hospitals in China (17), our findings may
prove valuable to health care policy makers in China. Our
prediction model reached a satisfactory result in predicting
mortality, in which most residuals in the model are concentrated
near 0, indicating nearly no difference between prediction and
observation. This demonstrates its effectiveness. To reach a better
sampling of the disease population, we are encouraging more
hospitals to submit their data to the database. The number of
participating centers continue to increase since its activation, and
in 2018, CGSD has 85 participating members.
Another limitation to our study is that this institutional level
database may not provide exclusive and conclusive answers
to many detailed questions. Our analysis did not include any
preoperative comorbidities or risk factors (e.g., weight loss or
American Society of Anesthesiologists score), which could also
influence surgical safety. The next step in data registration
is to conduct individual level data collection which includes
preoperative factors. The inclusion of such factors has begun
in several centers in 2017, and the analysis of said individual
data is on-going. It has been acknowledged that it is difficult
to collect all details for a national database. Neither ACS-
NSQIP nor the Japanese NCD included disease-specific data (e.g.,
staging and pathological outcomes) in their databases (8). This is
mainly subject to the purpose of their databases: surgical safety.
Moreover, maintaining such large-scale databases is challenging
(10). Improving our Chinese gastrointestinal union database by
learning from our international peers is necessary to ensure
its quality and cost-effectiveness. As the first application, our
analysis of the gross data still delivers many important insights
into the clinical practice.
In conclusion, we have reported the first risk stratification
study for gastric cancer surgeries, using a nationwide institutional
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level database. The surgical outcomes were satisfactory. These
identified risk factors could be used in reference for future
therapy selection, while serving as additional insight for Chinese
health care policy makers.
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